The use of molecular line probe assay for the detection of resistance to isoniazid and rifampicin: policy update

For persons with a sputum smear-positive specimen or a cultured isolate of MTBC, commercial molecular line-probe assay (LPA) may be used as the initial test instead of phenotypic culture-based DST to detect resistance to rifampicin and isoniazid